MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rush, R.
Right arrow Articles by Lindstrom, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rush, R.
Right arrow Articles by Lindstrom, J.

Vol. 61, Issue 6, 1416-1422, June 2002

First and Second Transmembrane Segments of alpha 3, alpha 4, beta 2, and beta 4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy and Potency of Nicotine

Ray Rush, Alexander Kuryatov, Mark E. Nelson, and Jon Lindstrom

Department of Neuroscience, University of Pennsylvania Medical School, Philadelphia, Pennsylvania

The first three transmembrane segments (M1-M3) of human nicotinic acetylcholine receptors (nAChRs) have been implicated in determining the efficacy of nicotine by studies of alpha 3/alpha 4 subunit chimeras (Kuryatov et al., 2000a). Nicotine has full efficacy on the alpha 4beta 2 nAChR and partial efficacy on the alpha 3beta 2 nAChR. Now, we have exchanged individually three amino acids between the alpha 4 and the alpha 3 subunits at positions 226(M1), 258(M2), and 262(M2). Also, similar exchanges were made in the beta 2 and beta 4 subunits at positions 224(M1), 226(M1), and 254(M2) (using alpha  subunit numbering). Expression of these mutated nAChRs in Xenopus laevis oocytes showed that the mutated M1 amino acids were important in influencing the potency of ACh and nicotine. It is hypothesized that these M1 amino acids affect the stability between the resting and activated states of the nAChR. M2 amino acids altered the efficacy of nicotine, usually without altering its potency. When the residue located at position 258 in the M2 region of the alpha  subunit was valine (as in the alpha 3 subunit), the resulting nAChR exhibited partial efficacy for nicotine that was voltage-dependent. Therefore, we believe that these M2 amino acids contribute to the formation of a binding site for nicotine in the alpha 3beta 2 nAChR channel, which results in a low-affinity channel block, causing the lower efficacy of nicotine on this nAChR.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. K. Staley, S. Krishnan-Sarin, K. P. Cosgrove, E. Krantzler, E. Frohlich, E. Perry, J. A. Dubin, K. Estok, E. Brenner, R. M. Baldwin, et al.
Human Tobacco Smokers in Early Abstinence Have Higher Levels of beta2* Nicotinic Acetylcholine Receptors than Nonsmokers.
J. Neurosci., August 23, 2006; 26(34): 8707 - 8714.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez
{alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine
Mol. Pharmacol., August 1, 2006; 70(2): 755 - 768.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, L. Cleemann, J. Lindstrom, and M. Morad
Differential Modulation of {beta}2 and {beta}4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification
Mol. Pharmacol., August 1, 2004; 66(2): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Salminen, K. L. Murphy, J. M. McIntosh, J. Drago, M. J. Marks, A. C. Collins, and S. R. Grady
Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice
Mol. Pharmacol., June 1, 2004; 65(6): 1526 - 1535.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics